JOHANNESBURG - Lenacapavir is described as a gamechanger in the fight against HIV/Aids. The long-acting prevention injection ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
1d
AHF: Study on Impact of Expanding Access to Lenacapavir in Latin America to Be Presented in Mexico
The AHF Global Public Health Institute for Latin America and the Caribbean, in collaboration with the National Institute of ...
4don MSNOpinion
The only thing standing between humanity and the end of HIV
A new drug called lenacapavir might entirely change the game, though.
President Cyril Ramaphosa has acknowledged in court papers that article 19 of the controversial Expropriation Act creates a ...
Zimbabwe is among 10 nations rolling out lenacapavir, a twice-yearly HIV prevention shot. "We are excited to announce that ...
Health Minister Dr Aaron Motsoaledi announced that the national rollout is expected to begin by March or April 2026, ...
O AHF Global Public Health Institute para a América Latina e Caribe, em parceria com o Instituto Nacional de Saúde Pública do ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
KZN to receive Lenacapavir,new long-acting HIV prevention injection. Minister Motsoaledi confirms rollout to 360 clinics, for ...
The South African on MSN
Lenacapavir rollout in South Africa and PEPFAR builds momentum
South Africa advances HIV prevention with the lenacapavir rollout in 2026, and the US approves the PEPFAR Bridge Plan for six months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback